group B Streptococci; prevention; neonatal infection
Abstract :
[en] Background & objectives: In Belgium, as in many other countries, group B Streptococcus (GBS) is still
the leading cause of sepsis and meningitis in neonates. In 2001, though no Belgian guidelines for their
prevention were available, in some hospitals, obstetrical programmes included a GBS prevention
policy. With an aim to reach a Belgian consensus for the prevention of perinatal group B streptococcal
disease, a national consensum meeting was organized in 2001. We report here our experience and
findings of this meeting.
Methods: In November 2001, obstetricians, neonatologists, microbiologists and infectious diseases
specialists were invited to participate in a GBS symposium. International and Belgian speakers
presented epidemiological aspects, argued comparative cost-effectiveness of different approaches for
prevention and debated technical and practical problems. Management of neonates with risk factors
for GBS disease and progress in GBS vaccines were also included in the programme. Further results
about Belgian obstetricians’ practice and compliance to a policy for prevention of neonatal GBS
diseases, as answered in two mail surveys, were commented and discussed. In an interactive session at
the end, each participant was asked to vote on the key points related to the different steps of the ideal
prevention strategy to recommend.
Results: For the main questions, 94 per cent of participants choose a screening-based approach and
94 per cent shifted from the current use of ampicillin to penicillin as first choice for antimicrobial
prophylaxis. Further, 79 per cent voted for an approach with integrated neonatal prophylaxis for
selected neonates at high risk for GBS disease and 47 per cent voted for a strategy based on an
intrapartum rapid screening-based approach.
Interpretation & conclusion: The state of the question by different speakers, the data from Belgian
epidemiology, and the debate about cost-effectiveness of different approaches led to a massive vote in
favour of the universal screening-based approach. Based on these results, a working group has been
appointed by the Ministry of Health to draft and edit Belgian recommendations for the prevention of
perinatal GBS disease.
Disciplines :
Laboratory medicine & medical technology Microbiology Immunology & infectious disease
Author, co-author :
Melin, Pierrette ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Microbiologie médicale et virologie médicale
Verschraegen, G.; University Hospital of Gent > Medical microbiology
Mahieu, L.; University of Antwerp > neonatalogy
Claeys, G.; University Hospital of Gent > Medical microbiology
De Mol, Patrick ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Microbiologie médicale et virologie médicale
Language :
English
Title :
Towards a Belgian consensus for prevention of perinatal group B streptococcal disease
Zangwill KM, Schuchat A, Wenger JD. Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. MMWR 1992; 41 (SS-6): 25-32.
Schuchat A, Wenger JD. Epidemiology of group B streptococcal disease: risk factors, prevention strategies, and vaccine development. Epidemiol Rev 1994; 16: 374-402.
Schuchat A. Group B streptococcus. Lancet 1999; 353: 51-6.
Ducoffre G. Surveillance des maladies infectieuses par un réseau de laboratoire de microbiologie 2000 + Tendances épidémiologiques 1983-1999, Septicémies et mé ningites néonatales. 2002, Institut Scientifique de la santé publique, section épidémiologie, Belgique.
Thesis: Melin P, Recherches sur l'épidémiologie du Streptococcus agalactiae B chez les parturientes et les nouveau-né s. , University of Liege, Belgium; 1987.
Melin P, Schmitz M, Heinrichs I, Hayette MP, Foidart JM, De Mot P. Prevention of neonatal group B streptococcal disease in Belgium: hospital policy, obstetricians practices and laboratory processing. In: 40th Intersciences Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 2000, Toronto, Canada, Abstract book, p. 459, no. 1746.
Melin P, Rodriguez Cuns G, Vicentino Fernandez W, De Mol P. Antimicrobial susceptibility of Streptococcus agalactiae isolated from patients in Belgium through 1989-1991 and 1996-1999. Proceedings of the XIV Lancefield International Symposium on Streptococci and Streptococcal Diseases; 1999 October, Auckland, New Zealand; November 2000, 305-9.
Melin P, Schmitz M, Tsobo C, Hayette MP, De Mol P. Rapid intrapartum test (Strep B OIA) and prenatal cultures for identification of group B streptococcal carriers at delivery: a prospective study, In: 40th Intersciences Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 2000, Toronto, Canada, Abstract book, p. 145, no. 357.
Melin P, Rodriguez Cuns G, Tsobo C, Hayette MP, Christiaens G, De Mol P. Prevalence of ermB, ermTR and mefA/B gene classes among erythromycin-resistant group B streptococcus isolates collected in Belgium. In: 39th annual meeting of the Infectious Diseases Society of America (IDSA), October 2001, San Francisco, USA, Abstract book, p. 128, no. 523.
Melin P, Keke D, Campo B, Hayette MP, Christiaens G, De Mol P. Serotype distribution of group B streptococci (GBS) in Belgium: isolates from neonatal infection in adult or colonization in pregnant woman. In: 42th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 2002, San Diego, USA, Abstract book, no. 1416.
Mahieu L, De Dooy J, Leys E. Obstetricians' compliance with CDC guidelines on maternal screening and intrapartum prophylaxis for group B streptococcus. J Obstet Gynecol 2000; 20: 460-4.
Melin P, Epidémiologie et prevention des infections néonatales à streptocoques du groupe B en Communauté Française, Recherche en médecine preventive ou en promotion de la santé, Ministère de la Communauté Française de Belgique, Rapport d'activité 1999-2000.
Melin P. Streptococcus agalactiae. In: Ducoffre G, Surveillance des maladies infectieuses par un réseau de laboratoire de inicrobiologie 2000 + Tendances épidé miologiques 1983-1999, 2002, Institut Scientifique de la santé publique, section épidémiologie, Belgique.
CDC. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR 1996; 45: 1-24.
CDC. Prevention of perinatal group B streptococcal disease: Revised guidelines from CDC. MMWR 2002; 51: 1-22.